000			01933 a2200541 4500
005			20250515053832.0
264		0	_c20070614
008			200706s 0 0 eng d
022			_a0197-0186
024	7		_a10.1016/j.neuint.2006.12.006 _2doi
040			_aNLM _beng _cNLM
100	1		_aLee, Daniel C
245	0	0	_a6-Hydroxydopamine induces cystatin C-mediated cysteine protease suppression and cathepsin D activation. _h[electronic resource]
260			_bNeurochemistry international _cMar 2007
300			_a607-18 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAnimals
650	0	4	_aCaspase 3 _xdrug effects
650	0	4	_aCathepsin B _xdrug effects
650	0	4	_aCathepsin D _xmetabolism
650	0	4	_aCell Death _xdrug effects
650	0	4	_aCystatin C
650	0	4	_aCystatins _xmetabolism
650	0	4	_aCysteine Endopeptidases _xmetabolism
650	0	4	_aDopamine _xmetabolism
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aEnzyme Activation _xdrug effects
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aLysosomes _xdrug effects
650	0	4	_aNeurons _xdrug effects
650	0	4	_aNeuroprotective Agents _xpharmacology
650	0	4	_aOxidative Stress _xdrug effects
650	0	4	_aOxidopamine _xtoxicity
650	0	4	_aPC12 Cells
650	0	4	_aParkinson Disease _xenzymology
650	0	4	_aPoly (ADP-Ribose) Polymerase-1
650	0	4	_aPoly(ADP-ribose) Polymerases _xdrug effects
650	0	4	_aRats
650	0	4	_aSympatholytics _xtoxicity
700	1		_aWomble, Tracy A
700	1		_aMason, Ceceile W
700	1		_aJackson, Inneke M
700	1		_aLamango, Nazarius S
700	1		_aSevers, Walter B
700	1		_aPalm, Donald E
773	0		_tNeurochemistry international _gvol. 50 _gno. 4 _gp. 607-18
856	4	0	_uhttps://doi.org/10.1016/j.neuint.2006.12.006 _zAvailable from publisher's website
999			_c16805082 _d16805082